EVALUASI INSEKTISIDA DELTAMETRIN 0,6% EC TERHADAP RHIPICEPHALUS SANGUINEUS
on
Authors:
I Wayan Sudira
Abstract:
“Parasit Rhipicephalus sanguineus (Acarina : Ixodidae) menyerang hewan peliharaan/ternak khususnya anjing, kambing dan babi. Penggunaan insektisida untuk mengendalikan parasit ini informasinya belum begitu banyak. Suatu percobaan untuk mengevaluasi insektisidaDeltametrin 0,6% EC terhadap Rhipicephalus sanguineus telah dilakukan di laboratorium pada bulan Mei , Juni, Juli 2007 di Denpasar. Hasilnya menunjukkan bahwa Deltametrin 0,6% Ec sangat baik untuk mengontrol Rhipicephalus sanguineus. Untuk pemakaian pada manusia perlu diteliti lebih lanjut.ABSTRACTParasite Rhipicephalus sanguineus (Acarina : Ixodidae) attack pets / livestock particulary dog, goat and pig. The information for the use of unsectiside to control by this parasite is scanly. An experimental study was caried out to evaluase the use of insentiside Deltamintri 0,6 % to control ofRhipicephalus sanguineus the study was condacted on May, June, July 2007 in Denpasar. The results of the study showed that Deltamentrin 0,6 % Ec is usefull to contrroly Rhipicephalus sanguineus shown LC50 happened to dosis 2,35 ppm and LC 95 happened to dosis 12 ppm. For usage on human being required to be more research.”
Keywords
Keyword Not Available
Downloads:
Download data is not yet available.
References
References Not Available
PDF:
https://jurnal.harianregional.com/buletinvet/full-2167
Published
2021-11-09
How To Cite
SUDIRA, I Wayan. EVALUASI INSEKTISIDA DELTAMETRIN 0,6% EC TERHADAP RHIPICEPHALUS SANGUINEUS.Buletin Veteriner Udayana, [S.l.], oct. 2012. ISSN 2477-2712. Available at: https://jurnal.harianregional.com/buletinvet/id-2167. Date accessed: 28 Aug. 2025.
Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian
Issue
Vol. 1 No. 1 Pebruari 2009
Section
Articles
Copyright
This work is licensed under a Creative Commons Attribution 4.0 International License
Discussion and feedback